Reduced platelet activity is more common than reported anti-platelet medication use in patients with intracerebral hemorrhage

Neurocritical Care

Volumn 11, Issue 3, 2009, Pages 307-310

  Naidech, Andrew M ^a   Bassin, Sarice L ^a   Bernstein, Richard A ^a   Batjer, H Hunt ^a   Alberts, Mark J ^a   Lindholm, Paul F ^a   Bleck, Thomas P ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Intracerebral hemorrhage; Platelets

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN;

ADULT; ANALYTIC METHOD; ANALYZER; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; CELL ASSAY; COMBINATION CHEMOTHERAPY; DRUG POTENCY; DRUG USE; FEMALE; HOSPITAL ADMISSION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

AGED; ASPIRIN; BLOOD PLATELETS; CEREBRAL HEMORRHAGE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PROSPECTIVE STUDIES; RISK FACTORS; TICLOPIDINE; WARFARIN;

EID: 71949100304     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12028-009-9219-7     Document Type: Article

References (20)

1. JP Broderick MN Diringer MD Hill NC Brun SA Mayer T Steiner BE Skolnick SM Davis 2007 Recombinant activated factor vii intracerebral hemorrhage trial investigators. Determinants of intracerebral hemorrhage growth-an exploratory analysis Stroke 38 1072 1075 10.1161/01.STR.0000258078.35316.30 10.1161/01.STR.0000258078.35316.30 1:CAS:528:DC%2BD2sXhslygu7w%3D 17290026 (Pubitemid 46568477)
2. J Flibotte N Hagan J O'Donnell S Greenberg J Rosand 2004 Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage Neurology 63 1059 1064 1:CAS:528:DC%2BD2cXntlOrsro%3D 15452298
3. P Saloheimo M Ahonen S Juvela J Pyhtinen E Savolainen M Hillborm 2006 Regular aspirin use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death Stroke 37 129 133 10.1161/01.STR.0000196991. 03618.31 10.1161/01.STR.0000196991.03618.31 1:CAS:528:DC%2BD2MXhtlagsb%2FI 16322483 (Pubitemid 43732060)
4. J Roquer A Rodriguez-Compello M Gomis A Ois E Munteis 2005 Previous anti-platelet therapy is an independent predictor of 30-day mortality after spontaneous supratentorial intracerebral hemorrhage J Neurol 252 412 416 10.1007/s00415-005-0659-5 10.1007/s00415-005-0659-5 1:CAS:528: DC%2BD2MXkvVWhtrk%3D 15739042 (Pubitemid 40576903)
5. C Foerch M Sitzer H Steinmetz T Neumann-Haefelin 2006 Pretreatment with anti-platelet agents is not independently associated with unfavorable outcome in intracerebral hemorrhage Stroke 37 2165 2167 10.1161/01.STR.0000231842.32153.74 10.1161/01.STR.0000231842.32153.74 1:CAS:528:DC%2BD28XmvFaksrc%3D 16809556 (Pubitemid 44309922)
6. Sansing LH, Messe SR, Cucchiara BL, Cohen SN, Lyden PD, Kasner SE. Chant investigators. Prior antiplatelet use does not affect hemorrhage growth or outcome after ich. Neurology. 2009; Jan 9 [Epub ahead of print]. doi 10.1212/01.wnl.0000342709.31341.88.
7. M Lordkipanidze C Pharand E Schampaert J Turgeon D Palisaitis J Diodati 2007 A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease Eur Heart J 28 1702 1708 10.1093/eurheartj/ehm226 10.1093/eurheartj/ehm226 1:CAS:528:DC%2BD2sXpvVKiur8%3D 17569678 (Pubitemid 47227104)
8. A Naidech R Bernstein K Levasseur S Bassin B Bendok H Batjer T Bleck MJ Alberts 2009 Platelet activity and outcome after intracerebral hemorrhage Ann Neurol 65 352 356 10.1002/ana.21618 10.1002/ana.21618 19334079
9. S Kundu E Heilmann R Sio C Garcia R Davidson R Ostgaard 1885 Description of an in vitro platelet function analyzer-pfa-100 Semin Thromb Hemost 21 106 112
10. J Dichiara K Bliden U Tantry S Chaganti R Kreutz T Gesheff Y Kreutz P Gurbel 2007 Platelet function measured by Verifynow identifies generalized high platelet reactivity in aspirin treated patients Platelets 18 414 423 10.1080/09537100701206824 10.1080/09537100701206824 1:CAS:528: DC%2BD2sXps1Gqu7o%3D 17763150 (Pubitemid 47347051)
11. The joint commission. Using medication reconciliation to prevent errors. 2008. http://www.jointcommission.org/SentinelEvents/SentinelEventAlert/sea-35. htm. Accessed on 16 June 2008.
12. V Serebruany A Malinin B Oshrine D Sane A Takserman D Atar C Hennekens 2004 Lack of uniform platelet activation in patients after ischemic stroke and choice of anti-platelet therapy Thromb Res 113 197 204 10.1016/j.thromres.2004. 03.002 10.1016/j.thromres.2004.03.002 1:CAS:528:DC%2BD2cXktVOjsr8%3D 15140583 (Pubitemid 38609404)
13. H Diener J Bogousslavsky LM Brass C Cimminiello L Csiba M Kaste D Leys J Matias-Guiu H Rupprecht 2004 Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (match): Randomised, double-blind, placebo-controlled trial Lancet 8431 331 337 10.1016/S0140-6736(04)16721-4 10.1016/S0140-6736(04)16721-4 (Pubitemid 38970009)
14. BS Karon A Wockenfus R Scott SJ Hartman JP McConnell PJ Santrach AS Jaffe 2008 Aspirin responsiveness in healthy volunteers measures with multiple assay platforms Clin Chem 54 1060 1065 10.1373/clinchem.2007.101014 10.1373/clinchem.2007.101014 1:CAS:528:DC%2BD1cXmvVarsLs%3D 18420732 (Pubitemid 351793414)
15. M Lordkipanidze C Pharand E Schampaert J Turgeon D Palisaitis J Diodati 2007 A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease Eur Heart J 28 1702 1708 10.1093/eurheartj/ehm226 10.1093/eurheartj/ehm226 1:CAS:528:DC%2BD2sXpvVKiur8%3D 17569678 (Pubitemid 47227104)
16. S Johnsen L Pedersen S Friis W Blot J McLaughlin J Olsen H Sørensen 2003 Nonaspirin nonsteroidal anti-inflammatory drugs and risk of hospitalization for intracerebral hemorrhage: A population-based case-control study Stroke 34 387 391 10.1161/01.STR.0000054057.11892.5B 10.1161/01.STR. 0000054057.11892.5B 1:CAS:528:DC%2BD3sXosVOhuw%3D%3D 12574547 (Pubitemid 36206335)
17. McEvoy G. American society of health system pharmacists. Afhs drug information. http://online.statref.com.ezproxy.galter.northwestern.edu/document. aspx?fxid=1&docid=531. Accessed on January 11.
18. JL Coleman MJ Alberts 2006 Effect of aspirin dose, preparation, and withdrawal on platelet response in normal volunteers Am J Cardiol. 98 838 841 10.1016/j.amjcard.2006.03.071 10.1016/j.amjcard.2006.03.071 1:CAS:528: DC%2BD28Xptlyrs7g%3D 16950199 (Pubitemid 44301025)
19. Hillbom ME, Huhtakangas JT. Platelet transfusion in acute intracerebral hemorrhage. Clinicaltrials.Gov number nct00699621. 2008. http://www. clinicaltrials.gov/ct2/show/NCT00699621. Accessed on 25 July 2008.
20. MJ Reeves E Smith G Fonarow A Hernandez W Pan LH Schwamm 2009 Off-hour admission and in-hospital stroke case fatality in the get with the guidelines-stroke program Stroke 40 569 576 10.1161/STROKEAHA.108.519355 10.1161/STROKEAHA.108.519355 18988914